NU SKIN ENTERPRISES INC - A (NUS) Stock Fundamental Analysis

NYSE:NUS • US67018T1051

8.48 USD
-0.15 (-1.74%)
At close: Feb 27, 2026
8.48 USD
0 (0%)
After Hours: 2/27/2026, 8:23:24 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to NUS. NUS was compared to 36 industry peers in the Personal Care Products industry. NUS has only an average score on both its financial health and profitability. NUS is valued quite cheap, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year NUS was profitable.
  • In the past year NUS had a positive cash flow from operations.
  • In multiple years NUS reported negative net income over the last 5 years.
  • NUS had a positive operating cash flow in 4 of the past 5 years.
NUS Yearly Net Income VS EBIT VS OCF VS FCFNUS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 7.69%, NUS is in the better half of the industry, outperforming 72.22% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 13.70%, NUS belongs to the top of the industry, outperforming 80.56% of the companies in the same industry.
  • NUS has a Return On Invested Capital of 4.08%. This is comparable to the rest of the industry: NUS outperforms 55.56% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for NUS is significantly below the industry average of 10.65%.
Industry RankSector Rank
ROA 7.69%
ROE 13.7%
ROIC 4.08%
ROA(3y)-1.25%
ROA(5y)2.75%
ROE(3y)-3.26%
ROE(5y)5.55%
ROIC(3y)5.22%
ROIC(5y)9.29%
NUS Yearly ROA, ROE, ROICNUS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

1.3 Margins

  • NUS has a better Profit Margin (7.02%) than 75.00% of its industry peers.
  • NUS has a Operating Margin of 3.87%. This is comparable to the rest of the industry: NUS outperforms 52.78% of its industry peers.
  • NUS's Operating Margin has declined in the last couple of years.
  • The Gross Margin of NUS (67.20%) is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of NUS has declined.
Industry RankSector Rank
OM 3.87%
PM (TTM) 7.02%
GM 67.2%
OM growth 3Y-34.86%
OM growth 5Y-23.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-2.13%
NUS Yearly Profit, Operating, Gross MarginsNUS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NUS is destroying value.
  • There is no outstanding debt for NUS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NUS Yearly Shares OutstandingNUS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
NUS Yearly Total Debt VS Total AssetsNUS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • NUS has an Altman-Z score of 3.70. This indicates that NUS is financially healthy and has little risk of bankruptcy at the moment.
  • With a decent Altman-Z score value of 3.70, NUS is doing good in the industry, outperforming 77.78% of the companies in the same industry.
  • The Debt to FCF ratio of NUS is 4.29, which is a neutral value as it means it would take NUS, 4.29 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of NUS (4.29) is better than 77.78% of its industry peers.
  • A Debt/Equity ratio of 0.26 indicates that NUS is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.26, NUS is in the better half of the industry, outperforming 61.11% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 4.29
Altman-Z 3.7
ROIC/WACC0.5
WACC8.23%
NUS Yearly LT Debt VS Equity VS FCFNUS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 2.15 indicates that NUS has no problem at all paying its short term obligations.
  • With a Current ratio value of 2.15, NUS perfoms like the industry average, outperforming 52.78% of the companies in the same industry.
  • A Quick Ratio of 1.45 indicates that NUS should not have too much problems paying its short term obligations.
  • NUS has a Quick ratio (1.45) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.15
Quick Ratio 1.45
NUS Yearly Current Assets VS Current LiabilitesNUS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • NUS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 51.76%, which is quite impressive.
  • The earnings per share for NUS have been decreasing by -18.78% on average. This is quite bad
EPS 1Y (TTM)51.76%
EPS 3Y-23.58%
EPS 5Y-18.78%
EPS Q2Q%-23.68%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-16.89%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • The Revenue is expected to grow by 1.05% on average over the next years.
EPS Next Y11.18%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-4.69%
Revenue Next 2Y1.05%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
NUS Yearly Revenue VS EstimatesNUS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
NUS Yearly EPS VS EstimatesNUS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

8

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 6.57 indicates a rather cheap valuation of NUS.
  • Based on the Price/Earnings ratio, NUS is valued cheaply inside the industry as 91.67% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 27.10, NUS is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 5.91, the valuation of NUS can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, NUS is valued cheaper than 88.89% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.06, NUS is valued rather cheaply.
Industry RankSector Rank
PE 6.57
Fwd PE 5.91
NUS Price Earnings VS Forward Price EarningsNUS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, NUS is valued cheaper than 100.00% of the companies in the same industry.
  • 88.89% of the companies in the same industry are more expensive than NUS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 7.75
EV/EBITDA 3.4
NUS Per share dataNUS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.59
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 2.77%, NUS has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 1.61, NUS pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.80, NUS pays a better dividend.
Industry RankSector Rank
Dividend Yield 2.77%

5.2 History

  • The dividend of NUS decreases each year by -30.50%.
  • NUS has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-30.5%
Div Incr Years0
Div Non Decr Years0
NUS Yearly Dividends per shareNUS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • NUS pays out 10.87% of its income as dividend. This is a sustainable payout ratio.
DP10.87%
EPS Next 2YN/A
EPS Next 3YN/A
NUS Yearly Income VS Free CF VS DividendNUS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M
NUS Dividend Payout.NUS Dividend Payout, showing the Payout Ratio.NUS Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

NU SKIN ENTERPRISES INC - A

NYSE:NUS (2/27/2026, 8:23:24 PM)

After market: 8.48 0 (0%)

8.48

-0.15 (-1.74%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)02-12
Earnings (Next)05-06
Inst Owners77.1%
Inst Owner Change1.1%
Ins Owners2.11%
Ins Owner Change11.64%
Market Cap413.40M
Revenue(TTM)N/A
Net Income(TTM)109.61M
Analysts45
Price TargetN/A
Short Float %3.7%
Short Ratio3.64
Dividend
Industry RankSector Rank
Dividend Yield 2.77%
Yearly Dividend0.24
Dividend Growth(5Y)-30.5%
DP10.87%
Div Incr Years0
Div Non Decr Years0
Ex-Date02-27
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)42.99%
Min EPS beat(2)12.21%
Max EPS beat(2)73.77%
EPS beat(4)4
Avg EPS beat(4)59.11%
Min EPS beat(4)12.21%
Max EPS beat(4)76.64%
EPS beat(8)7
Avg EPS beat(8)43.78%
EPS beat(12)10
Avg EPS beat(12)34.6%
EPS beat(16)13
Avg EPS beat(16)24.83%
Revenue beat(2)1
Avg Revenue beat(2)-1.07%
Min Revenue beat(2)-3.63%
Max Revenue beat(2)1.5%
Revenue beat(4)3
Avg Revenue beat(4)0.39%
Min Revenue beat(4)-3.63%
Max Revenue beat(4)2.51%
Revenue beat(8)5
Avg Revenue beat(8)-0.35%
Revenue beat(12)5
Avg Revenue beat(12)-1.28%
Revenue beat(16)7
Avg Revenue beat(16)-1.32%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)3.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.24%
Valuation
Industry RankSector Rank
PE 6.57
Fwd PE 5.91
P/S 0.26
P/FCF 7.75
P/OCF 4.62
P/B 0.52
P/tB 0.62
EV/EBITDA 3.4
EPS(TTM)1.29
EY15.21%
EPS(NY)1.43
Fwd EY16.91%
FCF(TTM)1.09
FCFY12.91%
OCF(TTM)1.83
OCFY21.64%
SpS32.01
BVpS16.41
TBVpS13.78
PEG (NY)0.59
PEG (5Y)N/A
Graham Number21.82
Profitability
Industry RankSector Rank
ROA 7.69%
ROE 13.7%
ROCE 5.16%
ROIC 4.08%
ROICexc 5.21%
ROICexgc 6.05%
OM 3.87%
PM (TTM) 7.02%
GM 67.2%
FCFM 3.42%
ROA(3y)-1.25%
ROA(5y)2.75%
ROE(3y)-3.26%
ROE(5y)5.55%
ROIC(3y)5.22%
ROIC(5y)9.29%
ROICexc(3y)6.41%
ROICexc(5y)12.52%
ROICexgc(3y)8.32%
ROICexgc(5y)17.24%
ROCE(3y)6.61%
ROCE(5y)11.76%
ROICexgc growth 3Y-45.58%
ROICexgc growth 5Y-28.67%
ROICexc growth 3Y-42.83%
ROICexc growth 5Y-26.9%
OM growth 3Y-34.86%
OM growth 5Y-23.31%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y-2.13%
F-Score6
Asset Turnover1.1
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 4.29
Debt/EBITDA 1.8
Cap/Depr 64.7%
Cap/Sales 2.31%
Interest Coverage 250
Cash Conversion 76.96%
Profit Quality 48.67%
Current Ratio 2.15
Quick Ratio 1.45
Altman-Z 3.7
F-Score6
WACC8.23%
ROIC/WACC0.5
Cap/Depr(3y)74.52%
Cap/Depr(5y)79.94%
Cap/Sales(3y)2.68%
Cap/Sales(5y)2.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.76%
EPS 3Y-23.58%
EPS 5Y-18.78%
EPS Q2Q%-23.68%
EPS Next Y11.18%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-16.89%
Revenue Next Year-4.69%
Revenue Next 2Y1.05%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-28.1%
EBIT growth 3Y-43.79%
EBIT growth 5Y-28.27%
EBIT Next Year155.65%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y39.66%
FCF growth 3Y-1.31%
FCF growth 5Y-8.9%
OCF growth 1Y-0.72%
OCF growth 3Y-7.59%
OCF growth 5Y-8.88%

NU SKIN ENTERPRISES INC - A / NUS FAQ

Can you provide the ChartMill fundamental rating for NU SKIN ENTERPRISES INC - A?

ChartMill assigns a fundamental rating of 5 / 10 to NUS.


What is the valuation status of NU SKIN ENTERPRISES INC - A (NUS) stock?

ChartMill assigns a valuation rating of 8 / 10 to NU SKIN ENTERPRISES INC - A (NUS). This can be considered as Undervalued.


How profitable is NU SKIN ENTERPRISES INC - A (NUS) stock?

NU SKIN ENTERPRISES INC - A (NUS) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for NUS stock?

The Price/Earnings (PE) ratio for NU SKIN ENTERPRISES INC - A (NUS) is 6.57 and the Price/Book (PB) ratio is 0.52.


Can you provide the dividend sustainability for NUS stock?

The dividend rating of NU SKIN ENTERPRISES INC - A (NUS) is 5 / 10 and the dividend payout ratio is 10.87%.